About CapsoVision, Inc.
Sector
Industry
CEO
Kang-Huai Wang
Website
Headquarters
Saratoga
Founded
2005
FIGI
BBG00KHZ9QJ2
CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CapsoVision, Inc. stocks are traded under the ticker CV.
CV stock has fallen by −30.00% compared to the previous week, the month change is a −30.00% fall, over the last year CapsoVision, Inc. has showed a −12.00% decrease.
Yes, you can track CapsoVision, Inc. financials in yearly and quarterly reports right on TradingView.
CV net income for the last quarter is −5.38 M USD, while the quarter before that showed −4.20 M USD of net income which accounts for −27.98% change. Track more CapsoVision, Inc. financial stats to get the full picture.
No, CV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CapsoVision, Inc. stock right from TradingView charts — choose your broker and connect to your account.